NIVF.US NewGenIvf Group Limited Class A Ordinary Shares

Healthcare Health Care Providers & Services USA Stocks
0.2062 USD
Close of Nov 17, 2026
0.1890 7,258
Market cap
USD 328K
P/E
-
P/B
0.01x
ROE
-121,613.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Sep 2026.

Is NIVF.US undervalued?

Graham number

The Graham number of NewGenIvf Group Limited Class A Ordinary Shares cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NewGenIvf Group Limited Class A Ordinary Shares fundamental analysis

No fundamental analysis for NewGenIvf Group Limited Class A Ordinary Shares yet.

NewGenIvf Group Limited Class A Ordinary Shares stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NewGenIvf Group Limited Class A Ordinary Shares

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freez…

Full company profile